← All news
Markets
Verici Dx (LSE:VRCI) Readies TranscripTx Launch: Can A Transplant Genetic Test Broaden Its Revenue Base?
Highlights TranscripTx is designed to identify genetic variants relevant to transplant recipients. The test will be offered as a laboratory developed test from Verici's accredited US lab. Verici says it is the only multi-gene panel develope…
Covered by 1 outlet
All coverage · 1 article